Walker grew up in a low-income housing project in New Jersey, spent portions of his young adulthood homeless, and began attending college in his thirties.
[4] In 2021, Walker published his book Neuroqueer Heresies: Notes on the Neurodiversity Paradigm, Autistic Empowerment, and Postnormal Possibilities, collecting his existing essays along with 120 pages of new material reflecting the subsequent evolution of his views.
[2] Walker writes an urban fantasy webcomic called Weird Luck, co-written by speculative fiction author Andrew M. Reichart and illustrated by artist Mike Bennewitz.
Though highly capable, Sojac suffers from a condition called Chronic Synchronicity Syndrome, also known as Weird Luck, which causes improbable events to occur around her.
[1] He has observed that for sufficiently experienced practitioners, Alli's ritual theatre techniques "can produce peak experiences … that are as intensely psychedelic as any LSD or psilocybin trip".
[1] Walker appears in several of the underground films Alli directed and produced during these years, including Orphans of Delirium (2004), The Greater Circulation (2005), The Mind Is a Liar and a Whore (2007), To Dream of Falling Upwards (2011), and dreambody/earthbody (2012).
Neuroqueering is a practice, or more accurately, a continually emergent and potentially infinite array of practices––modes of creatively subversive and transformative action in which anyone can choose to engage.
"[4] Robert Chapman writes that Walker's conceptualization of neuroqueering "has provided a new tool for combatting neuronormativity from within the constraints imposed by history and current material conditions.
[9] In his writings on neurodiversity he has noted that long-term alterations in cognitive functioning induced by "heavy usage of psychedelic drugs" can be considered a form of acquired neurodivergence.
The study, which Walker helped to design, produced clinically significant positive results, with participants who received MDMA experiencing substantially greater reduction in anxiety symptoms, an improvement which was found to have persisted or increased at the six-month follow-up point.